1[1]Topcuoglu M A, Haydari D, Ozturk S,et al. Plasma levels of coagulation and fibrinolysis markers in acute ischemic stroke patients with lone atrial. fibrillation.Neurol Sci, 2000,21:235-240. 被引量：1
2[2]Soncini M,Casazza F,Mattioli R,et al. Hypercoagulability and chronic atrial fibrillation: the role of markers of thrombin generation. Minerva Med, 1997,88: 504- 505. 被引量：1
4[4]Conway D S,Pearce L A,Chin B S,et al. Prognostic value of plasma yon Willebrand factor and soluble P-selec tin as indices of endothelial damage and pletelet activation in 994 patients with nonvalular atrial fibrillation.Circulation, 2003,107: 3141 - 3145. 被引量：1
5[5]Miklos S,Janos T,Erzsebet N,et al. D-dimer determination as screening tool to exclude atrial thrombi in atrial fibrillation. AmJ Cardiol, 2003, 92:85-87. 被引量：1
7[7]Eloni L,Peverill R E,Harper R W,et al. Coagulation in chronic atrial fibrillation. Circulation, 1997, 96:1053-1056. 被引量：1
8[8]Mahe I,Drouet L,Chassany O,et al. D-dimer:a characteristic of the coagulation state of each patient with chronic atrial fibrillation. Thromb Res, 2002,107:1 - 6. 被引量：1
9[9]Conway D S, Dwaynes G,Jan H, et al. Atrial fibrillation and the prothrombotic state in the elderly:the Rotterdam study. Stroke, 2003,34: 413- 417. 被引量：1
1Rosengren A, Wilhelmsen L, Eriksson E, et al. Lipeprotein(a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men. BMJ, 1990, 301 : 1248-1251. 被引量：1
2Budde T, Fechtrup C, Bosenberg E, et al. Plasma Lp (a) levels correlate with number, severity, and length-extension of coronary lesions in male patients undergoing coronary artefiography for clinically suspected coronary atherosclerosis. Arteriescler Thromb,1994, 14: 1730-1736. 被引量：1
3Sirikci O, Aytekin V, Demiroglu IC et al. Association of lipoprotein(a) concentration and apo (a) isoform size with restenosis after percutaneous transluminal coronary angloplasty. Int J Clin Lab Res,2000, 30:93-99. 被引量：1
4Miyata M, Biro S, Arima S, et al. High serum concentration of lipoprotein (a) is a risk factor for restenosis after percutaneous transluminal coronary angioplasty in Japanese patients with singlevessel disease. Am Heart J, 1996, 132 (2 Pt 1) :269-273. 被引量：1
5David J, Richard A, Rober S, et al. Relation of plasma lipoprotein(a) to infarct artery patency in survivors of myocardial infarction.Circulation, 1993, 88: 935-940. 被引量：1
6Igarashi Y, Yamaura M, Ito M, et al. Elevated serum lipoprotein(a) is a risk factor for left atrial thrombus in patients with chronic atrial fibrillation: A transesophageal echocardiographic study. Am Heart J, 1998 , 136: 965-971. 被引量：1
7Igarashi Y, Kasal H, Yamashita F, et al. Lipoprotein ( a), left atrial appendage function and thromboembolic risk in patients with chronic nonvalvular atrial fibrillation. Jpn Circ J, 2000, 64:93-98. 被引量：1
8Wolf PA. Abbott RD, Kannel WB. Atrial fibrillation: a major contributor to stroke in the elderly: The Framingham Study. Arch Intern Med, 1987, 147: 1561-1564. 被引量：1
9Li-Saw-Hee FL,Blann AD,Lip GYH.Effects of fixed low-dose warfarin, aspirin-warfarin combination therapy,and dose-adjusted warfarin on thrombogenesis in chronic atrial fibrillation.Stroke,2000,31∶828-833. 被引量：1
10Lip GYH,Lowe GDO,Rumley A,et al.Increased markers of thrombogenesis in chronic atrial fibrillation:Effects of Warfarin treatment.Br Heart J,1995,73∶527-533. 被引量：1
